PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
14-Mar-2024 Form Bio Helps Life Sciences Professionals Transform Omics Data Into Breakthrough Insights Through Google Cloud Newswire
14-Mar-2024 Future vaccine makers to get VR-assisted training centre of excellence RESILIENCE Centre of Excellence for UK Medicines Manufacturing Skills
14-Mar-2024 Google Cloud Announces New Generative AI Advancements for Healthcare and Life Science Organizations Google
14-Mar-2024 LSBU LAUNCHES ITS NEW INNOVATION CENTRE IN CROYDON The School of Engineering at LSBU
13-Mar-2024 MetrioPharm Establishes Scientific Advisory Board of Seasoned Immunology and Pediatric Experts MetrioPharm
12-Mar-2024 Eye Love Rock N’ Roll Benefit Concert to Support Holland Foundation for Sight Restoration at ASCRS Newswire
12-Mar-2024 New Report Reveals Top Life Sciences Marketing Trends Over the Past Year SCORR Marketing 
12-Mar-2024 Tuberculosis: MSF launches unprecedented project to tackle underdiagnosis among children TACTiC
12-Mar-2024 RHYTHM AI announces World’s first STAR ApolloTM Mapping System Cases with Pulsed Field Ablation RHYTHM AI Ltd
12-Mar-2024 medac unveils new Global Corporate Brand medac group
12-Mar-2024 Vaccine monitoring crucial as SARS-CoV-2 variants continue to evolve The Francis Crick Institute
12-Mar-2024 Major contract awarded for a Concussion research programme from the US Department of Defense University of Birmingham
12-Mar-2024 Elixirgen Scientific Achieves ISO 9001 QMS Certification Newswire
12-Mar-2024 CenExel Named Finalist for 'Best Clinical Trial Company' at World Vaccine Congress ViE Awards Newswire
11-Mar-2024 OncoZenge Explores Strategic Options for BupiZenge™ in China OncoZenge
11-Mar-2024 LSBU LAUNCHES ITS NEW INNOVATION CENTRE IN CROYDON DAY 2024 - NURTURING SMILES TO EMPOWER LIVES! The School of Engineering at LSBU
11-Mar-2024 Prolocor Announces Appointment of Raymond Russo as Chief Commercial Officer Newswire
08-Mar-2024 Empowering women in the pharma packaging boardroom MM Packaging
08-Mar-2024 Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab)-based quadruplet therapy for the treatment of patients with transplant-eligible, newly diagnosed multiple myeloma Johnson & Johnson
08-Mar-2024 Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab)-based quadruplet therapy for the treatment of patients with transplant-eligible, newly diagnosed multiple myeloma Johnson & Johnson